The Quiet Withdrawal
When a hospice patient in a rural county needs a hospital bed, an oxygen concentrator, or a pressure-relief mattress delivered to their home, the logistics chain behind that delivery is more fragile than most people realize. Regional durable medical equipment suppliers – the small and mid-size companies that have historically served rural hospice programs – are closing down, consolidating, or simply declining to renew service contracts in low-density markets. The withdrawal is happening without headlines, but its effects are landing directly on dying patients and the care teams trying to reach them.
The business case for exiting is straightforward: rural deliveries cost more, cover fewer patients per route, and generate thinner margins on reimbursement rates that Medicare sets nationally without adjusting for geography. A supplier driving 90 miles round-trip to deliver one piece of equipment gets paid the same rate as a supplier driving 12 miles in a suburban market. When fuel, labor, and vehicle maintenance costs keep rising, that math eventually stops working.
Some suppliers are not closing entirely – they are simply drawing tighter service maps.
Who Fills the Gap – and Who Doesn’t
The conventional assumption is that national chains step in when regional players exit. In practice, that substitution is incomplete. National suppliers do operate in rural areas, but they tend to prioritize markets where volume justifies maintaining a local warehouse or hub. In counties with sparse populations, national contracts often come with longer lead times, less flexibility on urgent after-hours calls, and less familiarity with local roads and access conditions. A rural hospice nurse coordinating care at 10 p.m. for a patient who needs repositioning equipment by morning is unlikely to find a national supplier ready to respond at that hour.
Hospice agencies themselves are absorbing some of the burden. Some programs have begun stocking basic equipment in-house, essentially building informal lending libraries of beds and supply kits that were previously handled entirely by the supplier side of the arrangement. This shift places new financial and logistical pressure on hospice organizations that are already operating under tight Medicare per-diem payments. They were not designed, staffed, or funded to double as equipment warehouses and delivery services.
Nonprofit hospice organizations in rural regions tend to feel this most acutely. They typically lack the capital reserves or operational scale to absorb equipment functions without sacrificing staffing elsewhere. For-profit hospice chains with rural footprints have more flexibility to renegotiate supplier contracts or vertically integrate equipment sourcing, but that option is not available to the independent community hospice programs that have historically been the primary end-of-life care provider in rural America.
Why the Reimbursement Structure Makes This Worse
Medicare’s hospice benefit was designed in the early 1980s and its core payment structure has not been overhauled to reflect the actual cost of rural service delivery. The per-diem rate paid to hospice agencies is meant to cover all care, including equipment and supplies. When suppliers price rural delivery into their contracts at a rate that eats significantly into that per-diem, hospice agencies face a choice between accepting unfavorable terms or going without a reliable supplier partner. Neither outcome serves the patient.
Federal rural health policy has addressed equipment access in primary and acute care settings with various geographic adjustment mechanisms, but the hospice equipment supply chain sits in a narrower regulatory space where those protections have not fully applied. There have been periodic advocacy efforts to push for rural add-on payments or adjusted reimbursement formulas, but legislative movement has been slow and supplier viability in thin markets remains an unresolved structural problem rather than a temporary disruption.
Some states have explored Medicaid-funded supplemental programs that pay suppliers additional amounts for rural deliveries, but these vary widely in design and coverage. A patient in one state may have access to a well-funded supplemental program; a patient in a neighboring state may have none. The result is a patchwork of access that depends heavily on where a person happens to be dying.
What Comes Next
Regional supplier consolidation is not unique to this sector – a pattern of smaller operators selling or shutting down as margins compress and national platforms expand has played out across healthcare-adjacent industries – but the consequences in hospice equipment are harder to absorb than in most markets, because the patients involved have no ability to wait, travel, or adapt. The open question is whether federal regulators will treat rural hospice equipment access as a genuine policy problem before the remaining regional suppliers in the most underserved counties finish running the numbers and reach the same conclusion as their predecessors.
